Home About Us Media Science & Research Customer Service
About Us
Dedicated to creating products to enhance wellness, PharmaNutrients supports research investigating fatty acids and soluble fibers. Activities encompass multiple technology platforms focused on creating solutions for obesity-related health issues including weight management, inflammation, diabetes and cardiovascular health.  PharmaNutrients’ principal intellectual property rights relate to conjugated linoleic acid (CLA) and chitosan, including an extensive portfolio of both its own in-house patents as well as in-licensed use patents and composition-of-matter patents including those of WARF (Wisconsin Alumni Research Foundation).

The firm researches and validates its intellectual property for license to business partners. PharmaNutrients is a privately held company located in the Chicago area.

Established in 1994, PharmaNutrients advanced the nutrition industry by developing two new ingredients and establishing two entirely new product categories. Originally formed as a joint venture with Natural ASA of Norway, PharmaNutrients initiated a de-merger in 1999 and continued independently to enhance its position as an industry leader.

Two platform technologies, conjugated linoleic acid and chitosan fiber, were and remain pivotal breakthroughs in weight management. By introducing Tonalin CLA, PharmaNutrients brought the first branded form of CLA to market and established a new category "body composition." In addition, PharmaNutrients introduced Absorbitol, the first commercial chitosan dietary supplement.

With the intention to develop new applications for CLA, PharmaNutrients sold its original Tonalin brand and continued to support research. The company then developed and launched CLA One, and after a successful introduction, divested of that CLA business to Lipid Nutrition of the Netherlands.

©2007 PharmaNutrients Inc. All Rights Reserved.